Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis
Clinical trial NCT03992261 · COMPLETED
Trial details
- NCT number
- NCT03992261
- Sponsor
- Mayne Pharma International Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-14
- Primary completion
- 2019-12-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.